|
1
|
Kelland L: The resurgence of
platinum-based cancer chemotherapy. Nat Rev Cancer. 7:573–584.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Barabas K, Milner R, Lurie D and Adin C:
Cisplatin: A review of toxicities and therapeutic applications. Vet
Comp Oncol. 6:1–18. 2008. View Article : Google Scholar
|
|
3
|
Hanigan MH and Devarajan P: Cisplatin
nephrotoxicity: Molecular mechanisms. Cancer Ther. 1:47–61.
2003.
|
|
4
|
McWhinney SR, Goldberg RM and McLeod HL:
Platinum neurotoxicity pharmacogenetics. Mol Cancer Ther. 8:10–16.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rybak LP: Mechanisms of cisplatin
ototoxicity and progress in otoprotection. Curr Opin Otolaryngol
Head Neck Surg. 15:364–369. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cubeddu LX: Mechanisms by which cancer
chemotherapeutic drugs induce emesis. Semin Oncol. 19(Suppl 15):
2–13. 1992.PubMed/NCBI
|
|
7
|
Yao X, Panichpisal K, Kurtzman N and
Nugent K: Cisplatin nephrotoxicity: A review. Am J Med Sci.
334:115–124. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pabla N and Dong Z: Cisplatin
nephrotoxicity: Mechanisms and renoprotective strategies. Kidney
Int. 73:994–1007. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Casares C, Ramírez-Camacho R, Trinidad A,
Roldán A, Jorge E and García-Berrocal JR: Reactive oxygen species
in apoptosis induced by cisplatin: Review of physiopathological
mechanisms in animal models. Eur Arch Otorhinolaryngol.
269:2455–2459. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Conklin KA: Dietary antioxidants during
cancer chemotherapy: Impact on chemotherapeutic effectiveness and
development of side effects. Nutr Cancer. 37:1–18. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sahin K, Sahin N and Kucuk O: Lycopene and
chemotherapy toxicity. Nutr Cancer. 62:988–995. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bhatt K, Zhou L, Mi QS, Huang S, She JX
and Dong Z: MicroRNA-34a is induced via p53 during cisplatin
nephrotoxicity and contributes to cell survival. Mol Med.
16:409–416. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang M, Wei Q, Pabla N, Dong G, Wang CY,
Yang T, Smith SB and Dong Z: Effects of hydroxyl radical scavenging
on cisplatin-induced p53 activation, tubular cell apoptosis and
nephrotoxicity. Biochem Pharmacol. 73:1499–1510. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sánchez-Pérez Y, Morales-Bárcenas R,
García-Cuellar CM, López-Marure R, Calderon-Oliver M,
Pedraza-Chaverri J and Chirino YI: The alpha-mangostin prevention
on cisplatin-induced apoptotic death in LLC-PK1 cells is associated
to an inhibition of ROS production and p53 induction. Chem Biol
Interact. 188:144–150. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ju SM, Pae HO, Kim WS, Kang DG, Lee HS and
Jeon BH: Role of reactive oxygen species in p53 activation during
cisplatin-induced apoptosis of rat mesangial cells. Eur Rev Med
Pharmacol Sci. 18:1135–1141. 2014.PubMed/NCBI
|
|
16
|
Xu Y, Wang C and Li Z: A new strategy of
promoting cisplatin chemotherapeutic efficiency by targeting
endoplasmic reticulum stress. Mol Clin Oncol. 2:3–7. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Peyrou M and Cribb AE: Effect of
endoplasmic reticulum stress preconditioning on cytotoxicity of
clinically relevant nephrotoxins in renal cell lines. Toxicol In
Vitro. 21:878–886. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cybulsky AV: Endoplasmic reticulum stress
in proteinuric kidney disease. Kidney Int. 77:187–193. 2010.
View Article : Google Scholar
|
|
19
|
Back SH, Scheuner D, Han J, Song B, Ribick
M, Wang J, Gildersleeve RD, Pennathur S and Kaufman RJ: Translation
attenuation through eIF2alpha phosphorylation prevents oxidative
stress and maintains the differentiated state in beta cells. Cell
Metab. 10:13–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qu L, Huang S, Baltzis D, Rivas-Estilla
AM, Pluquet O, Hatzoglou M, Koumenis C, Taya Y, Yoshimura A and
Koromilas AE: Endoplasmic reticulum stress induces p53 cytoplasmic
localization and prevents p53-dependent apoptosis by a pathway
involving glycogen synthase kinase-3beta. Genes Dev. 18:261–277.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee SK and Kim YS: Phosphorylation of
eIF2α attenuates statin-induced apoptosis by inhibiting the
stabilization and trans-location of p53 to the mitochondria. Int J
Oncol. 42:810–816. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
She QB, Chen N and Dong Z: ERKs and p38
kinase phosphorylate p53 protein at serine 15 in response to UV
radiation. J Biol Chem. 275:20444–20449. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hetz C, Chevet E and Harding HP: Targeting
the unfolded protein response in disease. Nat Rev Drug Discov.
12:703–719. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dey S, Sayers CM, Verginadis II, Lehman
SL, Cheng Y, Cerniglia GJ, Tuttle SW, Feldman MD, Zhang PJ, Fuchs
SY, et al: ATF4-dependent induction of heme oxygenase 1 prevents
anoikis and promotes metastasis. J Clin Invest. 125:2592–2608.
2015. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
He CH, Gong P, Hu B, Stewart D, Choi ME,
Choi AM and Alam J: Identification of activating transcription
factor 4 (ATF4) as an Nrf2-interacting protein. Implication for
heme oxygenase-1 gene regulation. J Biol Chem. 276:20858–20865.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Scheuner D, Song B, McEwen E, Liu C,
Laybutt R, Gillespie P, Saunders T, Bonner-Weir S and Kaufman RJ:
Translational control is required for the unfolded protein response
and in vivo glucose homeostasis. Mol Cell. 7:1165–1176. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Muaddi H, Majumder M, Peidis P, Papadakis
AI, Holcik M, Scheuner D, Kaufman RJ, Hatzoglou M and Koromilas AE:
Phosphorylation of eIF2α at serine 51 is an important determinant
of cell survival and adaptation to glucose deficiency. Mol Biol
Cell. 21:3220–3231. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Boyce M, Bryant KF, Jousse C, Long K,
Harding HP, Scheuner D, Kaufman RJ, Ma D, Coen DM, Ron D, et al: A
selective inhibitor of eIF2alpha dephosphorylation protects cells
from ER stress. Science. 307:935–939. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu CT, Sheu ML, Tsai KS, Chiang CK and Liu
SH: Salubrinal, an eIF2α dephosphorylation inhibitor, enhances
cisplatin-induced oxidative stress and nephrotoxicity in a mouse
model. Free Radic Biol Med. 51:671–680. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Martindale JL and Holbrook NJ: Cellular
response to oxidative stress: signaling for suicide and survival. J
Cell Physiol. 192:1–15. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Velasco G: Endoplasmic reticulum stressed
by pollution. Focus on 'Airborne particulate matter selectively
activates endoplasmic reticulum stress response in the lung and
liver tissues'. Am J Physiol Cell Physiol. 299:C727–C728. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Blais JD, Filipenko V, Bi M, Harding HP,
Ron D, Koumenis C, Wouters BG and Bell JC: Activating transcription
factor 4 is translationally regulated by hypoxic stress. Mol Cell
Biol. 24:7469–7482. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Agarwal A, Balla J, Alam J, Croatt AJ and
Nath KA: Induction of heme oxygenase in toxic renal injury: a
protective role in cisplatin nephrotoxicity in the rat. Kidney Int.
48:1298–1307. 1995. View Article : Google Scholar : PubMed/NCBI
|
